Akanda (AKAN) Common Equity (2020 - 2025)
Akanda (AKAN) recorded quarterly Common Equity of $4.3 million in Q4 2024, down 6.42% quarter-over-quarter from $4.6 million in Q2 2024, and up 211.69% on a YoY basis from $1.4 million in Q1 2024.
Akanda (AKAN) Common Equity (2020 - 2025) Analysis & Trends
Akanda's Common Equity history runs 5 years deep, the most recent figure standing at $4.3 million for Q4 2024.
- In Q4 2024, Common Equity rose 211.69% year-over-year to $4.3 million; the TTM figure through Dec 2024 stood at $4.3 million (up 211.69% YoY), while the FY2024 annual figure was $4.3 million, up 211.69% from the prior year.
- Common Equity was $4.3 million for Q4 2024 at Akanda, down from $4.6 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $34.6 million in Q2 2022 to a low of -$5.0 million in Q4 2020.
- Historically, Common Equity has averaged $10.1 million across 5 years, with a median of $4.4 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Common Equity jumped 1321.94% in 2022, then slumped 114.23% in 2023.
- A 5-year view of Common Equity shows it stood at -$5.0 million in 2020, then jumped by 56.25% to -$2.2 million in 2021, then surged by 1321.94% to $26.9 million in 2022, then tumbled by 114.23% to -$3.8 million in 2023, then jumped by 211.69% to $4.3 million in 2024.
- The last three Common Equity figures came in at $4.3 million (Q4 2024), $4.6 million (Q2 2024), and -$3.8 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Akanda | 826.99 Mn | 824.46 Mn | - | -11.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.99 Mn |
| Dec 31, 2024 | 4.28 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Dec 31, 2023 | -3.83 Mn |
| Jun 30, 2023 | 21.65 Mn |
| Dec 31, 2022 | 26.90 Mn |
| Jun 30, 2022 | 34.64 Mn |
| Dec 31, 2021 | -2.20 Mn |
| Dec 31, 2020 | -5.03 Mn |